Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Liraglutide is a medication that is FDA-approved, prescription only.
Also known as Saxenda, Victoza, generic liraglutide
Liraglutide was the first GLP-1 medication approved for chronic weight management (Saxenda) and is also used for type 2 diabetes (Victoza). FDA approved generic versions of Victoza in December 2024 and of Saxenda in August 2025, which can make it a lower-cost option.

Approved by the FDA. A licensed clinician has to decide it is right for you and prescribe it. FDA-approved, prescription only, including generics. FDA's April 2026 proposal would also exclude liraglutide from the 503B outsourcing bulks list.
As of September 23, 2026.
Key takeaways
Liraglutide is a modified version of GLP-1, the gut hormone that signals fullness. Natural GLP-1 breaks down within minutes; liraglutide is built to last much longer, so it keeps appetite signals turned down through the day.
It also helps the pancreas release insulin when blood sugar is high, which is how Victoza treats type 2 diabetes.



Randomized trials (the SCALE program) show moderate average weight loss, generally less than newer weekly GLP-1 drugs.
What trials and prescribing information measured over time. Everyone responds differently.
Treatment starts low and increases gradually. Tiredness, dizziness and taste changes were reported mostly in the first 12 weeks, often alongside GI symptoms.
The label says to check progress at 16 weeks and stop if weight loss is below its threshold.
In SCALE, participants lost about 8 kg on average, versus about 3 kg on placebo. About 63% lost at least 5% of body weight, versus 27% on placebo.
Liraglutide has solid trial evidence, but guidelines now see it as a less effective option than newer weekly GLP-1 drugs. Generics have made it a lower-cost choice.
The AGA 2022 guideline suggests liraglutide as one option for long-term weight management in adults with obesity, based on moderate-certainty evidence.
AGA clinical practice guideline on pharmacological interventions for obesity (2022)The Saxenda label says to check your weight 16 weeks after starting and stop if you have lost less than 4% of your starting weight, since meaningful long-term loss is then unlikely.
DailyMed: Saxenda (liraglutide) prescribing informationThe Endocrine Society's obesity drug guideline advises continuing a weight-loss medication only if it is working at about three months, and considering alternatives if not.
Endocrine Society: Pharmacological management of obesity, clinical practice guidelineFDA approved the first generic of Victoza in December 2024, and a generic of Saxenda followed in 2025.
FDA (Dec 2024): First generic of once-daily GLP-1 injection approvedSummaries of published guidelines, drug labels, regulators and reviews, each attributed to its source. DiscoverMedica does not employ clinicians.
Only a licensed clinician who knows your history can decide whether it is right for you.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Answer an online health questionnaire about your weight history, conditions and medications.
A licensed clinician reviews it. Depending on your state and the program, that is either an asynchronous review or a short video or phone visit.
Some programs ask for recent labs, or send an at-home kit, before or soon after prescribing.
If prescribed, the medication ships to you or is sent to a local pharmacy. Branded pens covered by insurance usually need a prior authorization first.
Follow-ups happen by message or visit as your clinician adjusts treatment, typically monthly early on.
Some services let you order common lab tests yourself, so the results are ready for your visit. Your clinician decides which labs, if any, you need, and what the results mean.
From each service’s own site, checked September 23, 2026.
From each provider’s own site, checked September 23, 2026. Programs change, so confirm the details before you sign up.
12 providers list Liraglutide on DiscoverMedica, lowest listed price first.
† Prices as listed by the provider when we checked; they change.
Listed prices run from $160 to $279 a month across 2 providers, as checked October 7, 2026.
Prices as listed by the provider when we checked; they change. Membership or consult fees may be separate; see each provider.
Both are GLP-1 drugs. Liraglutide is taken daily and, in trials, led to less average weight loss than weekly semaglutide. Generic liraglutide can be cheaper.
Yes. FDA approved generic Victoza in 2024 and generic Saxenda in 2025.
The Saxenda label builds in a check at 16 weeks. If you have not lost enough weight by then, it says to stop and talk about other options.
Nausea, diarrhea, constipation and vomiting are the most common, especially early on. The label also warns about pancreatitis, gallbladder problems, faster heart rate and mood changes.
Yes. Several telehealth providers prescribe it, often sent to a local pharmacy.
This is not a complete list of risks. Read the full prescribing information and any Medication Guide, and talk to a licensed clinician or pharmacist about your own situation. If you have a severe reaction, call 911. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.
Guide reviewed September 23, 2026.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An investigational triple-hormone weight-loss drug from Eli Lilly. Not approved; only available in trials.
A cheap, decades-old diabetes pill that some people ask about for weight and healthy aging.